Trial Outcomes & Findings for Computerized Alcohol Screening for Children and Adolescents (cASCA) in Primary Care (NCT NCT02233946)
NCT ID: NCT02233946
Last Updated: 2021-03-11
Results Overview
Median (and interquartile range) for times to first use for the cSBI and Treatment As Usual (TAU) groups
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
871 participants
Primary outcome timeframe
12-months follow-up
Results posted on
2021-03-11
Participant Flow
Participant milestones
| Measure |
Computerized Screening w/ Provider Brief Intervention (cSBI)
cSBI consists of adolescents self-administering on a tablet computer a screening questionnaire prior to seeing their provider. The computer program then immediately provides adolescents with personalized feedback, followed by brief psychoeducation illustrating the health-related risks of substance use. Providers then login to the tablet computer to access a Clinician Report Form which presents the patient's screening results, as well as discussion prompts to guide a few minutes of Motivational Interviewing-based brief counseling during the visit.
|
Computerized Screening With Treatment as Usual (TAU)
The comparison group also completed the computerized screening tool. However, this group did not receive any feedback or psychoeducation, and their providers did not receive the screening results. During the visit, adolescents in this group received treatment as usual.
|
|---|---|---|
|
Baseline
STARTED
|
628
|
243
|
|
Baseline
COMPLETED
|
626
|
243
|
|
Baseline
NOT COMPLETED
|
2
|
0
|
|
Immediate Post-visit Questionnaire
STARTED
|
626
|
243
|
|
Immediate Post-visit Questionnaire
COMPLETED
|
624
|
243
|
|
Immediate Post-visit Questionnaire
NOT COMPLETED
|
2
|
0
|
|
3-months Follow-up
STARTED
|
624
|
243
|
|
3-months Follow-up
COMPLETED
|
571
|
214
|
|
3-months Follow-up
NOT COMPLETED
|
53
|
29
|
|
6-months Follow-up
STARTED
|
571
|
214
|
|
6-months Follow-up
COMPLETED
|
550
|
212
|
|
6-months Follow-up
NOT COMPLETED
|
21
|
2
|
|
9-month Follow-up
STARTED
|
550
|
212
|
|
9-month Follow-up
COMPLETED
|
530
|
201
|
|
9-month Follow-up
NOT COMPLETED
|
20
|
11
|
|
12-month Follow-up
STARTED
|
530
|
201
|
|
12-month Follow-up
COMPLETED
|
502
|
190
|
|
12-month Follow-up
NOT COMPLETED
|
28
|
11
|
Reasons for withdrawal
| Measure |
Computerized Screening w/ Provider Brief Intervention (cSBI)
cSBI consists of adolescents self-administering on a tablet computer a screening questionnaire prior to seeing their provider. The computer program then immediately provides adolescents with personalized feedback, followed by brief psychoeducation illustrating the health-related risks of substance use. Providers then login to the tablet computer to access a Clinician Report Form which presents the patient's screening results, as well as discussion prompts to guide a few minutes of Motivational Interviewing-based brief counseling during the visit.
|
Computerized Screening With Treatment as Usual (TAU)
The comparison group also completed the computerized screening tool. However, this group did not receive any feedback or psychoeducation, and their providers did not receive the screening results. During the visit, adolescents in this group received treatment as usual.
|
|---|---|---|
|
Baseline
Withdrawal by Subject
|
2
|
0
|
|
3-months Follow-up
Lost to Follow-up
|
53
|
29
|
|
6-months Follow-up
Lost to Follow-up
|
21
|
2
|
|
9-month Follow-up
Lost to Follow-up
|
20
|
11
|
|
12-month Follow-up
Lost to Follow-up
|
28
|
11
|
Baseline Characteristics
We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
Baseline characteristics by cohort
| Measure |
Computerized Screening w/ Provider Brief Intervention (cSBI)
n=626 Participants
cSBI consists of adolescents self-administering on a tablet computer a screening questionnaire prior to seeing their provider. The computer program then immediately provides adolescents with personalized feedback, followed by brief psychoeducation illustrating the health-related risks of substance use. Providers then login to the tablet computer to access a Clinician Report Form which presents the patient's screening results, as well as discussion prompts to guide a few minutes of Motivational Interviewing-based brief counseling during the visit.
|
Computerized Screening With Treatment as Usual (TAU)
n=243 Participants
The comparison group also completed the computerized screening tool. However, this group did not receive any feedback or psychoeducation, and their providers did not receive the screening results. During the visit, adolescents in this group received treatment as usual.
|
Total
n=869 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
Participants who reported past-12-month use of alcohol or other drugs at baseline
|
16.3 years
STANDARD_DEVIATION 1.3 • n=148 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
16.5 years
STANDARD_DEVIATION 1.3 • n=63 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
16.4 years
STANDARD_DEVIATION 1.3 • n=211 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
|
Age, Continuous
Participants who reported no past-12-month use of alcohol or other drugs at baseline
|
14.1 years
STANDARD_DEVIATION 1.8 • n=478 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
14.5 years
STANDARD_DEVIATION 1.7 • n=180 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
14.3 years
STANDARD_DEVIATION 1.8 • n=658 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
|
Sex: Female, Male
Participants who reported past-12-month use of alcohol or other drugs at baseline · Female
|
80 Participants
n=148 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
34 Participants
n=63 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
114 Participants
n=211 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
|
Sex: Female, Male
Participants who reported past-12-month use of alcohol or other drugs at baseline · Male
|
68 Participants
n=148 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
29 Participants
n=63 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
97 Participants
n=211 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
|
Sex: Female, Male
Participants who reported no past-12-month use of alcohol or other drugs at baseline · Female
|
236 Participants
n=478 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
91 Participants
n=180 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
327 Participants
n=658 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
|
Sex: Female, Male
Participants who reported no past-12-month use of alcohol or other drugs at baseline · Male
|
242 Participants
n=478 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
89 Participants
n=180 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
331 Participants
n=658 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
|
Race/Ethnicity, Customized
Participants who reported past-12-month use of alcohol or other drugs at baseline · Non-Hispanic White
|
69 Participants
n=148 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
36 Participants
n=63 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
105 Participants
n=211 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
|
Race/Ethnicity, Customized
Participants who reported past-12-month use of alcohol or other drugs at baseline · Hispanic
|
40 Participants
n=148 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
15 Participants
n=63 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
55 Participants
n=211 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
|
Race/Ethnicity, Customized
Participants who reported past-12-month use of alcohol or other drugs at baseline · Other or multirace
|
39 Participants
n=148 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
12 Participants
n=63 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
51 Participants
n=211 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
|
Race/Ethnicity, Customized
Participants who reported no past-12-month use of alcohol or other drugs at baseline · Non-Hispanic White
|
203 Participants
n=478 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
79 Participants
n=180 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
282 Participants
n=658 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
|
Race/Ethnicity, Customized
Participants who reported no past-12-month use of alcohol or other drugs at baseline · Hispanic
|
143 Participants
n=478 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
58 Participants
n=180 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
201 Participants
n=658 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
|
Race/Ethnicity, Customized
Participants who reported no past-12-month use of alcohol or other drugs at baseline · Other or multirace
|
132 Participants
n=478 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
43 Participants
n=180 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
175 Participants
n=658 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
|
Region of Enrollment
United States
|
626 Participants
n=626 Participants
|
243 Participants
n=243 Participants
|
869 Participants
n=869 Participants
|
|
In grades 9-12
Participants who reported past-12-month use of alcohol or other drugs at baseline · Yes
|
141 Participants
n=148 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
60 Participants
n=63 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
201 Participants
n=211 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
|
In grades 9-12
Participants who reported past-12-month use of alcohol or other drugs at baseline · No
|
7 Participants
n=148 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
3 Participants
n=63 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
10 Participants
n=211 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
|
In grades 9-12
Participants who reported no past-12-month use of alcohol or other drugs at baseline · Yes
|
197 Participants
n=478 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
100 Participants
n=180 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
297 Participants
n=658 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
|
In grades 9-12
Participants who reported no past-12-month use of alcohol or other drugs at baseline · No
|
281 Participants
n=478 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
80 Participants
n=180 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
361 Participants
n=658 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
|
Lives with two parents in home
Participants who reported past-12-month use of alcohol or other drugs at baseline · Yes
|
103 Participants
n=148 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
41 Participants
n=63 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
144 Participants
n=211 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
|
Lives with two parents in home
Participants who reported past-12-month use of alcohol or other drugs at baseline · No
|
45 Participants
n=148 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
22 Participants
n=63 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
67 Participants
n=211 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
|
Lives with two parents in home
Participants who reported no past-12-month use of alcohol or other drugs at baseline · Yes
|
380 Participants
n=478 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
143 Participants
n=180 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
523 Participants
n=658 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
|
Lives with two parents in home
Participants who reported no past-12-month use of alcohol or other drugs at baseline · No
|
98 Participants
n=478 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
37 Participants
n=180 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
135 Participants
n=658 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
|
Parent highest education level is college graduate or higher
Participants who reported past-12-month use of alcohol or other drugs at baseline · Yes
|
100 Participants
n=148 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
44 Participants
n=63 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
144 Participants
n=211 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
|
Parent highest education level is college graduate or higher
Participants who reported past-12-month use of alcohol or other drugs at baseline · No
|
48 Participants
n=148 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
19 Participants
n=63 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
67 Participants
n=211 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
|
Parent highest education level is college graduate or higher
Participants who reported no past-12-month use of alcohol or other drugs at baseline · Yes
|
306 Participants
n=478 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
108 Participants
n=180 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
414 Participants
n=658 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
|
Parent highest education level is college graduate or higher
Participants who reported no past-12-month use of alcohol or other drugs at baseline · No
|
172 Participants
n=478 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
72 Participants
n=180 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
244 Participants
n=658 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
|
Saw a pediatrician at visit
Participants who reported past-12-month use of alcohol or other drugs at baseline · Yes
|
128 Participants
n=148 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
50 Participants
n=63 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
178 Participants
n=211 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
|
Saw a pediatrician at visit
Participants who reported past-12-month use of alcohol or other drugs at baseline · No
|
20 Participants
n=148 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
13 Participants
n=63 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
33 Participants
n=211 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
|
Saw a pediatrician at visit
Participants who reported no past-12-month use of alcohol or other drugs at baseline · Yes
|
412 Participants
n=478 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
152 Participants
n=180 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
564 Participants
n=658 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
|
Saw a pediatrician at visit
Participants who reported no past-12-month use of alcohol or other drugs at baseline · No
|
66 Participants
n=478 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
28 Participants
n=180 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
94 Participants
n=658 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
|
Saw a female practitioner
Participants who reported past-12-month use of alcohol or other drugs at baseline · Yes
|
99 Participants
n=148 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
50 Participants
n=63 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
149 Participants
n=211 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
|
Saw a female practitioner
Participants who reported past-12-month use of alcohol or other drugs at baseline · No
|
49 Participants
n=148 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
13 Participants
n=63 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
62 Participants
n=211 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
|
Saw a female practitioner
Participants who reported no past-12-month use of alcohol or other drugs at baseline · Yes
|
321 Participants
n=478 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
117 Participants
n=180 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
438 Participants
n=658 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
|
Saw a female practitioner
Participants who reported no past-12-month use of alcohol or other drugs at baseline · No
|
157 Participants
n=478 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
63 Participants
n=180 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
220 Participants
n=658 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
|
Had 6 or more prior visits with practitioner
Participants who reported past-12-month use of alcohol or other drugs at baseline · Yes
|
90 Participants
n=148 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
33 Participants
n=63 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
123 Participants
n=211 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
|
Had 6 or more prior visits with practitioner
Participants who reported past-12-month use of alcohol or other drugs at baseline · No
|
58 Participants
n=148 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
30 Participants
n=63 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
88 Participants
n=211 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
|
Had 6 or more prior visits with practitioner
Participants who reported no past-12-month use of alcohol or other drugs at baseline · Yes
|
284 Participants
n=478 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
106 Participants
n=180 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
390 Participants
n=658 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
|
Had 6 or more prior visits with practitioner
Participants who reported no past-12-month use of alcohol or other drugs at baseline · No
|
194 Participants
n=478 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
74 Participants
n=180 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
268 Participants
n=658 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
|
Had CRAFFT score of 2 or greater
Yes
|
41 Participants
n=148 Participants • Participants who reported past-12-month use of alcohol or other drugs at baseline
|
18 Participants
n=63 Participants • Participants who reported past-12-month use of alcohol or other drugs at baseline
|
59 Participants
n=211 Participants • Participants who reported past-12-month use of alcohol or other drugs at baseline
|
|
Had CRAFFT score of 2 or greater
No
|
107 Participants
n=148 Participants • Participants who reported past-12-month use of alcohol or other drugs at baseline
|
45 Participants
n=63 Participants • Participants who reported past-12-month use of alcohol or other drugs at baseline
|
152 Participants
n=211 Participants • Participants who reported past-12-month use of alcohol or other drugs at baseline
|
|
Hung out with friends who use alcohol/drugs
Participants who reported past-12-month use of alcohol or other drugs at baseline · Yes
|
131 Participants
n=148 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
57 Participants
n=63 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
188 Participants
n=211 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
|
Hung out with friends who use alcohol/drugs
Participants who reported past-12-month use of alcohol or other drugs at baseline · No
|
17 Participants
n=148 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
6 Participants
n=63 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
23 Participants
n=211 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
|
Hung out with friends who use alcohol/drugs
Participants who reported no past-12-month use of alcohol or other drugs at baseline · Yes
|
169 Participants
n=478 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
82 Participants
n=180 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
251 Participants
n=658 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
|
Hung out with friends who use alcohol/drugs
Participants who reported no past-12-month use of alcohol or other drugs at baseline · No
|
309 Participants
n=478 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
98 Participants
n=180 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
407 Participants
n=658 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
|
Has substance-involved siblings
Participants who reported past-12-month use of alcohol or other drugs at baseline · Yes
|
59 Participants
n=148 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
23 Participants
n=63 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
82 Participants
n=211 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
|
Has substance-involved siblings
Participants who reported past-12-month use of alcohol or other drugs at baseline · No
|
89 Participants
n=148 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
40 Participants
n=63 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
129 Participants
n=211 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
|
Has substance-involved siblings
Participants who reported no past-12-month use of alcohol or other drugs at baseline · Yes
|
40 Participants
n=478 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
10 Participants
n=180 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
50 Participants
n=658 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
|
Has substance-involved siblings
Participants who reported no past-12-month use of alcohol or other drugs at baseline · No
|
438 Participants
n=478 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
170 Participants
n=180 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
608 Participants
n=658 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
|
Has substance-involved parents/guardians
Participants who reported past-12-month use of alcohol or other drugs at baseline · Yes
|
25 Participants
n=148 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
10 Participants
n=63 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
35 Participants
n=211 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
|
Has substance-involved parents/guardians
Participants who reported past-12-month use of alcohol or other drugs at baseline · No
|
123 Participants
n=148 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
53 Participants
n=63 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
176 Participants
n=211 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
|
Has substance-involved parents/guardians
Participants who reported no past-12-month use of alcohol or other drugs at baseline · Yes
|
27 Participants
n=478 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
8 Participants
n=180 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
35 Participants
n=658 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
|
Has substance-involved parents/guardians
Participants who reported no past-12-month use of alcohol or other drugs at baseline · No
|
451 Participants
n=478 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
172 Participants
n=180 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
623 Participants
n=658 Participants • We conducted analyses stratified by past-12-month use of any alcohol or other drugs reported at baseline
|
PRIMARY outcome
Timeframe: 12-months follow-upPopulation: Stratified: Participants who reported past-12-month use of alcohol or other drugs at baseline vs. Participants who reported no past-12-month use of alcohol or other drugs at baseline
Median (and interquartile range) for times to first use for the cSBI and Treatment As Usual (TAU) groups
Outcome measures
| Measure |
Computerized Screening w/ Provider Brief Intervention (cSBI)
n=570 Participants
cSBI consists of adolescents self-administering on a tablet computer a screening questionnaire prior to seeing their provider. The computer program then immediately provides adolescents with personalized feedback, followed by brief psychoeducation illustrating the health-related risks of substance use. Providers then login to the tablet computer to access a Clinician Report Form which presents the patient's screening results, as well as discussion prompts to guide a few minutes of Motivational Interviewing-based brief counseling during the visit.
|
Computerized Screening With Treatment as Usual (TAU)
n=212 Participants
The comparison group also completed the computerized screening tool. However, this group did not receive any feedback or psychoeducation, and their providers did not receive the screening results. During the visit, adolescents in this group received treatment as usual.
|
|---|---|---|
|
Time to First Post-visit Drinking Day
Participants who reported past-12-month use of alcohol or other drugs at baseline
|
97 days
Interval 51.0 to 222.0
|
44 days
Interval 21.0 to 143.0
|
|
Time to First Post-visit Drinking Day
Participants who reported no past-12-month use of alcohol or other drugs at baseline
|
366 days
Interval 338.0 to 366.0
|
366 days
Interval 334.0 to 366.0
|
PRIMARY outcome
Timeframe: 12-months follow-upPopulation: Participants who reported past-12-month use of alcohol or other drugs at baseline
The number of days post-visit to first reported heavy episodic drinking day
Outcome measures
| Measure |
Computerized Screening w/ Provider Brief Intervention (cSBI)
n=114 Participants
cSBI consists of adolescents self-administering on a tablet computer a screening questionnaire prior to seeing their provider. The computer program then immediately provides adolescents with personalized feedback, followed by brief psychoeducation illustrating the health-related risks of substance use. Providers then login to the tablet computer to access a Clinician Report Form which presents the patient's screening results, as well as discussion prompts to guide a few minutes of Motivational Interviewing-based brief counseling during the visit.
|
Computerized Screening With Treatment as Usual (TAU)
n=46 Participants
The comparison group also completed the computerized screening tool. However, this group did not receive any feedback or psychoeducation, and their providers did not receive the screening results. During the visit, adolescents in this group received treatment as usual.
|
|---|---|---|
|
Time to First Post-visit Heavy Episodic Drinking Day
|
366 days
Interval 124.0 to 366.0
|
213 days
Interval 51.0 to 366.0
|
SECONDARY outcome
Timeframe: 12-months follow-upPopulation: Stratified: Participants who reported past-12-month use of alcohol or other drugs at baseline vs. Participants who reported no past-12-month use of alcohol or other drugs at baseline
The number of days post-visit to first reported cannabis use day.
Outcome measures
| Measure |
Computerized Screening w/ Provider Brief Intervention (cSBI)
n=516 Participants
cSBI consists of adolescents self-administering on a tablet computer a screening questionnaire prior to seeing their provider. The computer program then immediately provides adolescents with personalized feedback, followed by brief psychoeducation illustrating the health-related risks of substance use. Providers then login to the tablet computer to access a Clinician Report Form which presents the patient's screening results, as well as discussion prompts to guide a few minutes of Motivational Interviewing-based brief counseling during the visit.
|
Computerized Screening With Treatment as Usual (TAU)
n=191 Participants
The comparison group also completed the computerized screening tool. However, this group did not receive any feedback or psychoeducation, and their providers did not receive the screening results. During the visit, adolescents in this group received treatment as usual.
|
|---|---|---|
|
Time to First Post-visit Cannabis Use Day
Participants who reported past-12-month use of alcohol or other drugs at baseline
|
101 Days
Interval 33.0 to 226.0
|
83 Days
Interval 27.0 to 152.0
|
|
Time to First Post-visit Cannabis Use Day
Participants who reported no past-12-month use of alcohol or other drugs at baseline
|
366 Days
Interval 366.0 to 366.0
|
366 Days
Interval 366.0 to 366.0
|
SECONDARY outcome
Timeframe: 12 months follow-upPopulation: Participants with riding risk at baseline vs. those with no riding risk at baseline. (Differences in number of participants analyzed at each follow-up time point is due to number of survey respondents at that time point. For example, in the cSBI group at baseline, 64 participants reported having riding risk. At 3 months follow-up, 44 of those completed a survey, and 20 of those 44 reported having riding risk at the 3-months follow-up.)
Self-reported riding in the past 3 months with a driver who had been drinking or using other drugs, stratified by reported riding risk in the past 3 months at baseline
Outcome measures
| Measure |
Computerized Screening w/ Provider Brief Intervention (cSBI)
n=625 Participants
cSBI consists of adolescents self-administering on a tablet computer a screening questionnaire prior to seeing their provider. The computer program then immediately provides adolescents with personalized feedback, followed by brief psychoeducation illustrating the health-related risks of substance use. Providers then login to the tablet computer to access a Clinician Report Form which presents the patient's screening results, as well as discussion prompts to guide a few minutes of Motivational Interviewing-based brief counseling during the visit.
|
Computerized Screening With Treatment as Usual (TAU)
n=243 Participants
The comparison group also completed the computerized screening tool. However, this group did not receive any feedback or psychoeducation, and their providers did not receive the screening results. During the visit, adolescents in this group received treatment as usual.
|
|---|---|---|
|
Past-3-month Riding Risk
Riding risk at baseline : Baseline, No.
|
64 participants
|
35 participants
|
|
Past-3-month Riding Risk
Riding risk at baseline : 6 months
|
20 participants
|
12 participants
|
|
Past-3-month Riding Risk
Riding risk at baseline : 9 months
|
16 participants
|
13 participants
|
|
Past-3-month Riding Risk
Riding risk at baseline : 12 months
|
18 participants
|
13 participants
|
|
Past-3-month Riding Risk
No riding risk at baseline : Baseline, No.
|
561 participants
|
208 participants
|
|
Past-3-month Riding Risk
No riding risk at baseline : 6 months
|
35 participants
|
19 participants
|
|
Past-3-month Riding Risk
No riding risk at baseline : 9 months
|
33 participants
|
10 participants
|
|
Past-3-month Riding Risk
No riding risk at baseline : 12 months
|
28 participants
|
11 participants
|
Adverse Events
Computerized Screening w/ Provider Brief Intervention (cSBI)
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Computerized Screening With Treatment as Usual (TAU)
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place